T1	Participants 58 129	hypertensive patients inadequately controlled by fimasartan monotherapy
T2	Participants 413 520	Patients with sitting diastolic blood pressure (siDBP) â‰¥90 mmHg with 4 weeks of once-daily fimasartan 60 mg
T3	Participants 827 910	263 randomized patients, 256 patients who had available efficacy data were analyzed
